Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04021524Phase 4Completed
Phase 4, randomised, open-label trial of benzoyl peroxide in Cutibacterium acnes colonization (2 arms), sponsored by University of Washington. Primary endpoints: Number of Patients With a Positive Propionibacteria Swabs and Number of Quadrants on Culture Plate of Propionibacteria Growth. Started Sep 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04021524.